| Nanog inhibits lipopolysaccharide-induced expression of pro-inflammatory cytokines by blocking NF-κB transcriptional activity in rat primary microglial cells. | |
| | |
MedLine Citation:
|
PMID: 22200792 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Nanog is an essential transcription factor maintaining the self-renewal and pluripotency of embryonic stem cells, which binds to nuclear factor-κB (NF-κB) proteins, inhibits their transcriptional activity and represses their pro-differentiation activity. The persistent and excessive activation of microglial cells, as primary immune cells in the central nervous system is associated with various nerve system diseases, such as neuropathic pain, ischemia, infection, as well as neurodegenerative diseases. However, the effects of Nanog on the activation of microglial cells have yet to be elucidated. In this study, we investigated whether Nanog inhibits the production of pro-inflammatory factors in lipopolysaccharide (LPS)-stimulated microglial cells. Nanog was shown to down-regulate the mRNA and protein levels of IL-1β, TNF-α and IL-6 in LPS-stimulated rat primary microglial cells. Furthermore, we also found that the transcriptional activity of NF-κB was dramatically reduced by Nanog, which was measured using luciferase assay. The results suggest that Nanog reduces the production of pro-inflammatory cytokines and attenuates inflammatory responses in LPS-stimulated microglial cells by blocking the transcriptional activity of NF-κB. Thus, Nanog may be a potentially useful anti-inflammatory therapy for the treatment of various nervous system diseases. |
| | |
Authors:
|
Haitao Zhou; Shiyan Chen; Wei Wang; Zhiqiang Wang; Xiuli Wu; Zhijian Zhang |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2011-12-19 |
Journal Detail:
|
Title: Molecular medicine reports Volume: 5 ISSN: 1791-3004 ISO Abbreviation: Mol Med Rep Publication Date: 2012 Mar |
Date Detail:
|
Created Date: 2012-01-05 Completed Date: 2012-05-03 Revised Date: 2013-02-22 |
Medline Journal Info:
|
Nlm Unique ID: 101475259 Medline TA: Mol Med Rep Country: Greece |
Other Details:
|
Languages: eng Pagination: 842-6 Citation Subset: IM |
Affiliation:
|
Neurology Department, The First Affiliated Hospital of Fujian Medical University, Fuzhou, PR China. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adjuvants, Immunologic
/
pharmacology Animals Anti-Inflammatory Agents / pharmacology Cells, Cultured Cytokines / genetics, metabolism* Gene Expression Regulation, Enzymologic / drug effects* Interleukin-1beta / genetics, metabolism Interleukin-6 / genetics, metabolism Lipopolysaccharides / pharmacology Microglia / cytology, drug effects*, enzymology* NF-kappa B / antagonists & inhibitors, genetics, metabolism* Rats Recombinant Proteins / genetics, metabolism, pharmacology Transcription Factors / genetics, metabolism, pharmacology* Tumor Necrosis Factor-alpha / genetics, metabolism |
| Chemical | |
Reg. No./Substance:
|
0/Adjuvants, Immunologic; 0/Anti-Inflammatory Agents; 0/Cytokines; 0/Interleukin-1beta; 0/Interleukin-6; 0/Lipopolysaccharides; 0/NF-kappa B; 0/Nanog protein, rat; 0/Recombinant Proteins; 0/Transcription Factors; 0/Tumor Necrosis Factor-alpha |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Relative biological effectiveness of high linear energy transfer ?-particles for the ind...
Next Document: Gastrointestinal quality of life after laparoscopic-assisted sigmoidectomy for diverticular disease.